Global Patent Index - EP 1677817 A1

EP 1677817 A1 20060712 - G-CSF THERAPY AS AN ADJUNCT TO REPERFUSION THERAPY IN THE TREATMENT OF ACUTE MYOCARDIAL INFARCTION

Title (en)

G-CSF THERAPY AS AN ADJUNCT TO REPERFUSION THERAPY IN THE TREATMENT OF ACUTE MYOCARDIAL INFARCTION

Title (de)

G-CSF-THERAPIE ALS HILFSMITTEL FÜR DIE REPERFUSIONSTHERAPIE BEI DER BEHANDLUNG VON AKUTEM MYOKARDINFARKT

Title (fr)

RECOURS A LA THERAPIE PAR G-CSF COMME ADJUVANT A LA THERAPIE PAR REPERFUSION DANS LE CADRE DU TRAITEMENT DE L'INFARCTUS AIGU DU MYOCARDE

Publication

EP 1677817 A1 20060712 (EN)

Application

EP 04789111 A 20040927

Priority

  • US 2004031704 W 20040927
  • US 69457903 A 20031027

Abstract (en)

[origin: US2005089507A1] The present invention relates to methods of using Granulocyte Colony Stimulating Factor (G-CSF) polypeptide in conjunction with reperfusion therapy in the treatment of acute myocardial infarction or other ischemic events. This treatment can be used alone or in combination with other well-known methods of treatment.

IPC 1-7

A61K 38/19; A61P 9/10

IPC 8 full level

A61K 38/19 (2006.01); A61K 38/27 (2006.01)

CPC (source: EP US)

A61K 38/193 (2013.01 - EP US); A61P 9/10 (2018.01 - EP)

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

DOCDB simple family (publication)

US 2005089507 A1 20050428; US 7220407 B2 20070522; AU 2004287369 A1 20050519; CA 2543481 A1 20050519; EP 1677817 A1 20060712; US 2007258945 A1 20071108; WO 2005044296 A1 20050519

DOCDB simple family (application)

US 69457903 A 20031027; AU 2004287369 A 20040927; CA 2543481 A 20040927; EP 04789111 A 20040927; US 2004031704 W 20040927; US 78418807 A 20070405